Tao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tao Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Anquan Qin
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
1 shared publication - Dan Wang
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
1 shared publication - Haotian Li
The Fifth Medical Center Chinese PLA General Hospital Beijing China
1 shared publication - Honglin Liu
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication - Huadan Cai
Department of Pharmacy, Fifth Medical Center, General Hospital of Chinese PLA, Beijing, 100039, China
1 shared publication - Jiabo Wang
China Military Institute of Chinese Medicine, Fifth Medical Center, General Hospital of Chinese PLA, Beijing, 100039, China
1 shared publication
Latest Publications
- 3 June 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 363, 110008
Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
- 3 June 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 363, 110008
Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
- Open Access
- 11 July 2019
- Published by Springer Nature in AMB Express
- Vol. 9 (1) , 1-10
Antibacterial evaluation of plants extracts against ampicillin-resistant Escherichia coli (E. coli) by microcalorimetry and principal component analysis
Antibiotics abuse has caused increased bacterial resistance, which severely limits the application of antibiotics to the treatment of bacterial infections. Therefore, it is urgent to develop new antibacterial drugs through other sources. Dracontomelon dao (Blanco) Merr. & Rolfe (Ren Mianzi in Chinese) is a traditional medicinal material derived from Anacardiaceae with a long history of treating various infectious diseases, such as decubitus and skin ulcers. Recent research has indicated that different extracts from the leaves of D. dao, especially the ethyl acetate (EtOAc) fraction containing flavonoids and phenolic acids, exhibit potent antibacterial activities. In this research, the combined anti-drug-resistant bacterial activities of these active ingredients were investigated. Six samples (S1–S6) were obtained from the EtOAc fraction of D. dao leaves. Microcalorimetric measurements and principal component analysis were performed on the in vitro samples. The results showed that all six samples had notable antibacterial activities. Specifically, sample S6 exhibited a prominent antibacterial effect, with an IC50 value of 84.3 μg mL−1, which was significantly lower than that of other samples. The relative contents of main flavonoids and phenolic acids in S6 sample were confirmed by UPLC/Q-TOF-MS. In conclusion, sample S6 from the EtOAc fraction of D. dao leaves could be used as a potential antimicrobial resource in the treatment of infectious diseases. This work provides an insight into the effect of traditional Chinese medicine on drug-resistant bacteria. Moreover, the purification and characterization of the chemical compounds from the sample S6 deserve further analysis.
- 11 July 2019
- Published by Springer Nature in AMB Express
- Vol. 9 (1) , 1-10
Open AccessAntibacterial evaluation of plants extracts against ampicillin-resistant Escherichia coli (E. coli) by microcalorimetry and principal component analysis
Antibiotics abuse has caused increased bacterial resistance, which severely limits the application of antibiotics to the treatment of bacterial infections. Therefore, it is urgent to develop new antibacterial drugs through other sources. Dracontomelon dao (Blanco) Merr. & Rolfe (Ren Mianzi in Chinese) is a traditional medicinal material derived from Anacardiaceae with a long history of treating various infectious diseases, such as decubitus and skin ulcers. Recent research has indicated that different extracts from the leaves of D. dao, especially the ethyl acetate (EtOAc) fraction containing flavonoids and phenolic acids, exhibit potent antibacterial activities. In this research, the combined anti-drug-resistant bacterial activities of these active ingredients were investigated. Six samples (S1–S6) were obtained from the EtOAc fraction of D. dao leaves. Microcalorimetric measurements and principal component analysis were performed on the in vitro samples. The results showed that all six samples had notable antibacterial activities. Specifically, sample S6 exhibited a prominent antibacterial effect, with an IC50 value of 84.3 μg mL−1, which was significantly lower than that of other samples. The relative contents of main flavonoids and phenolic acids in S6 sample were confirmed by UPLC/Q-TOF-MS. In conclusion, sample S6 from the EtOAc fraction of D. dao leaves could be used as a potential antimicrobial resource in the treatment of infectious diseases. This work provides an insight into the effect of traditional Chinese medicine on drug-resistant bacteria. Moreover, the purification and characterization of the chemical compounds from the sample S6 deserve further analysis.